Understanding Attention-Deficit/Hyperactivity Disorder from Childhood to Adulthood

References

• . Greenhill LL, Pliszka S, Dulcan MK, . Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry. 2002;41( 2 suppl):26S–49S
   PubMed Web of Science ®Google Scholar
• . American Academy of Pediatrics. Subcommittee on Attention-Deficit/Hyperactivity Disorder and Committee on Quality Improvement. Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics. 2001;108(4):1033–1044
   PubMedGoogle Scholar
• . Biederman J, Monuteaux M, Mick E, . Young adult outcome of attention deficit hyperactivity disorder: a controlled 10 year follow-up study. Psychol Med. 2006;36(2):167–179
   PubMed Web of Science ®Google Scholar
• . Swanson J, Lerner M, Gupta S, . Development of a new once-a-day formulation of methylphenidate for the treatment of ADHD: proof-of-concept and proof-of-product studies. Arch Gen Psychiatry. 2003;60(2):204–211
   PubMed Web of Science ®Google Scholar
• . Barkley R. Major life activity and health outcomes associated with attention-deficit hyperactivity disorder. J Clin Psychiatry. 2002;63 ( supp 12):10–15
   PubMed Web of Science ®Google Scholar
• . Wilens TE, Spencer T. Attention-deficit/hyperactivity disorders, lifetime course and strategies for intervention. In: Howlin P, Charman T, Ghaziuddin M, eds. The SAGE Handbook of Developmental Disorders. London, UK: Sage Publications; 2010
   Google Scholar
• . Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007;164(6):942–948
   PubMed Web of Science ®Google Scholar
• . Kessler RC, Adler L, Barkley R, . The prevalence and correlates of adult ADHD in the United States: results from the national comorbidity survey replication. Am J Psychiatry. 2006;163(4):716–723
   PubMed Web of Science ®Google Scholar
• . Centers for Disease Control and Prevention (CDC). Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder-United States, 2003. MMWR Morb Mortal Wkly Rep. 2005;54(34):842–847
   PubMedGoogle Scholar
• . Biederman J, Faraone SV, Monuteaux M, Bober M, Cadogen E. Gender effects of attention deficit hyperactivity disorder in adults, revisited. Biol Psychiatry. 2004;55(7):692–700
   PubMed Web of Science ®Google Scholar
• . Anderson JC, Williams S, McGee R, Silva PA. DSM III disorders in preadolescent children. Prevalence in a large sample from the general population. Arch Gen Psychiatry. 1987;44(1):69–76
   PubMed Web of Science ®Google Scholar
• . Bird HR, Gould MS, Staghezza BM. Patterns of diagnostic comorbidity in a community sample of children aged 9 through 16 years. J Am Acad Child Adolesc Psychiatry. 1993;32(2):361–368
   Google Scholar
• . Abikoff H, McGough J, Vitiello B, ; RUPP ADHD/Anxiety Study Group. Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders. J Am Acad Child Adolesc Psychiatry. 2005;44(5):418–427
   Google Scholar
• . Jensen PS, Shervette RE 3rd, Xenakis SN, Richters J. Anxiety and depressive disorders in attention deficit hyperactivity disorder with hyperactivity: new findings. Am J Psychiatry. 1993;150(8):1203–1209
   PubMed Web of Science ®Google Scholar
• . Biederman J, Monuteaux MC, Spencer T, Wilens TE, Faraone SV. Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study. Pediatrics. 2009;124(1):71–78
   PubMed Web of Science ®Google Scholar
• . Faraone SV, Biederman J, Wozniak J, Mundy E, Mennin D, O'Donnell D. Is comorbidity with ADHD a marker for juvenile-onset mania? J Am Acad Child Adolesc Psychiatry. 1997;36(8):1046–1055
   Google Scholar
• . Wilens TE, Biederman J, Wozniak J, Gunawardene S, Wong J, Monuteaux M. Can adults with attention-deficit hyperactivity disorder be distinguished from those with comorbid bipolar disorder: findings from a sample of clinically referred adults. Biol Psychiatry. 2003;54(1):1–8
   PubMed Web of Science ®Google Scholar
• . Wilens TE, Biederman J. Alcohol, drugs, and attention-deficit/hyperactivity disorder: a model for the study of addictions in youth. J Psychopharmacol. 2006;20(4):580–588
   PubMed Web of Science ®Google Scholar
• . Wilens TE, Vitulano M, Upadhyaya H, . Cigarette smoking associated with attention deficit hyperactivity disorder. J Pediatr. 2008;153(3):414–419
   PubMed Web of Science ®Google Scholar
• . Kollins SH, McClernon FJ, Fuemmeler BF. Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults. Arch Gen Psychiatry. 2005;62(10):1142–1147
   PubMed Web of Science ®Google Scholar
• . Biederman J, Monuteaux MC, Mick E, . Is cigarette smoking a gateway drug to subseqeunt alcohol and illicit drug use disorders? A controlled study of youths with and without attention deficit hyperactivity disorder. Biol Psychiatry. 2006;59(3):258–264
   PubMed Web of Science ®Google Scholar
• . Wilens TE, Biederman J, Mick E. Does ADHD affect the course of substance abuse? Findings from a sample of adults with and without ADHD. Am J Addict. 1998;7(2):156–163
   PubMed Web of Science ®Google Scholar
• . Levin FR, Evans SM. Diagnostic and treatment issues in comorbid substance abuse and adult attention-deficit hyperactivity disorder. Psychiatric Annals. 2001;31(5):303–312
   Google Scholar
• . Wilson JJ, Levin FR. Attention-deficit/hyperactivity disorder and early-onset substance use disorders. J Child Adolesc Psychopharmacol. 2005;15(5):751–763
   PubMed Web of Science ®Google Scholar
• . Vitiello B. Long-term effects of stimulant medications on the brain: possible relevance to the treatment of attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol. 2001;11(1):25–34
   PubMed Web of Science ®Google Scholar
• . Wilens TE, Adamson J, Monuteaux MC, . Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents. Arch Pediatr Adolesc Med. 2008;162(10):916–921
   PubMed Web of Science ®Google Scholar
• . Biederman J, Monuteaux MC, Spencer T, Wilens TE, Macpherson HA, Faraone SV. Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study. Am J Psychiatry. 2008;165(5):597–603
   PubMed Web of Science ®Google Scholar
• . Barkley RA, Biederman J. Toward a broader definition of the age-of-onset criterion for attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1997;36(9):1204–1210
   PubMed Web of Science ®Google Scholar
• . American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Association; 2000
   Google Scholar
• . American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
   Google Scholar
• . Wilens TE, Biederman J, Faraone S, Martelon M, Westerberg D, Spencer T. Presenting ADHD symptoms, subtypes, and comorbid disorders in clinically referred adults with ADHD. J Clin Psychiatry. 2009;70(11):1557–1562
   PubMed Web of Science ®Google Scholar
• . Millstein RB, Wilens TE, Biederman J, Spencer TJ. Presenting ADHD symptoms and subtypes in clinically referred adults with ADHD. J Attention Disord. 1997;2(3):159–166
   Google Scholar
• . Lahey BB, Pelham WE, Loney J, Lee SS, Willcutt E. Instability of the DSM-IV subtypes of ADHD from preschool through elementary school. Arch Gen Psychiatry. 2005;62(8):896–902
   PubMed Web of Science ®Google Scholar
• . Mannuzza S, Klein RG, Moulton JL 3rd. Young adult outcome of children with “situational” hyperactivity: a prospective, controlled follow-up study. J Abnorm Child Psychol. 2002;30(2):191–198
   PubMed Web of Science ®Google Scholar
• . Massachusetts General Hospital. School Psychiatry Program and Madi Resource Center. http://www2.massgeneral.org/schoolpsychiatry/. Accessed August 12, 2010
   Google Scholar
• . Adler L, Cohen J. Diagnosis and evaluation of adults with ADHD. In: Spencer T, ed. Psychiatric Clinics of North America. Vol 27. Philadelphia, PA: Saunders Press; 2004:187–201
   Google Scholar
• . Sandra Kooij JJ, Marije Boonstra A, Swinkels SH, Bekker EM, de Noord I, Buitelaar JK. Reliability, validity, and utility of instruments for self-report and informant report concerning symptoms of ADHD in adult patients. J Atten Disord. 2008;11(4):445–458
   PubMed Web of Science ®Google Scholar
• . Kessler RC, Adler L, Ames M, . The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005;35(2):245–256
   PubMed Web of Science ®Google Scholar
• . Mick E, Faraone SV, Biederman J, Spencer T. The course and outcome of ADHD. Prim Psychiatry. 2004;11(7):42–48
   Google Scholar
• . Biederman J, Faraone S, Mick E. Age-dependent decline of ADHD symptoms revisited: impact of remission definition and symptom subtype. Am J Psychiatry. 2000;157(5):816–818
   PubMed Web of Science ®Google Scholar
• . Hart EL, Lahey BB, Loeber R, Applegate B, Frick PJ. Developmental change in attention-deficit hyperactivity disorder in boys: a four-year longitudinal study. J Abnorm Child Psychol. 1995;23(6):729–749
   PubMed Web of Science ®Google Scholar
• . Martinussen R, Hayden J, Hogg-Johnson S, Tannock R. A meta-analysis of working memory impairments in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2005;44(4):377–384
   PubMed Web of Science ®Google Scholar
• . Barkley RA. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull. 1997;121(1):65–94
   PubMed Web of Science ®Google Scholar
• . Seidman LJ. Neuropsychological functioning in people with ADHD across the lifespan. Clin Psychol Rev. 2006;26(4):466–485
   PubMed Web of Science ®Google Scholar
• . de Zeeuw P, Aarnoudse-Moens C, Bijlhout J, . Inhibitory performance, response speed, intraindividual variability, and response accuracy in ADHD. J Am Acad Child Adolesc Psychiatry. 2008;47(7):808–816
   PubMed Web of Science ®Google Scholar
• . Sergeant JA, Geurts H, Oosterlaan J. How specific is a deficit of executive functioning for attention-deficit/hyperactivity disorder? Behav Brain Res. 2002;130(1–2):3–28
   PubMed Web of Science ®Google Scholar
• . Sonuga-Barke E, Dalen L, Remington B. Do executive deficits and delay aversion make independent contributions to preschool attention-deficit/hyperactivity disorder symptoms? J Am Acad Child Adolesc Psychiatry. 2003;42(11):1335–1342
   PubMed Web of Science ®Google Scholar
• . Shaw P, Lalonde F, Lepage C, . Development of cortical asymmetry in typically developing children and its disruption in attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2009;66(8):888–896
   Google Scholar
• . McAlonan GM, Cheung V, Chua SE, . Age-related grey matter volume correlates of response inhibition and shifting in attention-deficit hyperactivity disorder. Br J Psychiatry. 2009;194(2):123–129
   PubMed Web of Science ®Google Scholar
• . Cole WR, Mostofsky SH, Larson JC, Denckla MB, Mahone EM. Age-related changes in motor subtle signs among girls and boys with ADHD. Neurology. 2008;71(19):1514–1520
   PubMed Web of Science ®Google Scholar
• . Ivanov I, Bansal R, Hao X, . Morphological abnormalities of the thalamus in youths with attention deficit hyperactivity disorder. Am J Psychiatry. 2010;167(4):397–408
   PubMed Web of Science ®Google Scholar
• . Hervey AS, Epstein J, Curry JF. The neuropsychology of adults with attention deficit hyperactivity disorder: a meta-analytic review. Neuropsychology. 2004;18(3):485–503
   PubMed Web of Science ®Google Scholar
• . Seidman L, Doyle A, Fried R, Valera E, Crum K, Matthews L. Neuropsychological functioning in adults with attention-deficit/hyperactivity disorder. In: Spencer T, ed. Adult ADHD, Psychiatric Clinics of North America. Vol 27. Amsterdam, The Netherlands: Elsevier Science; 2004:261–282
   Google Scholar
• . Biederman J, Monuteaux MC, Doyle AE, . Impact of executive function deficits and ADHD on academic outcomes in children. J Consult Clin Psychol. 2004;72(5):757–766
   PubMed Web of Science ®Google Scholar
• . Castellanos FX, Lee PP, Sharp W, . Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA. 2002;288(14):1740–1748
   PubMed Web of Science ®Google Scholar
• . Seidman LJ, Valera EM, Makris N, . Dorsolateral prefrontal and anterior cingulate cortex volumetric abnormalities in adults with attention-deficit/hyperactivity disorder identified by magnetic resonance imaging. Biol Psychiatry. 2006;60(10):1071–1080
   PubMedGoogle Scholar
• . Shaw P, Eckstrand K, Sharp W, . Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc Natl Acad Sci U S A. 2007;104(49):19649–19654
   PubMed Web of Science ®Google Scholar
• . Makris N, Biederman J, Valera EM, . Cortical thinning of the attention and executive function networks in adults with attention-deficit/hyperactivity disorder. Cerebral Cortex. 2007;17(6):1364–1375
   PubMed Web of Science ®Google Scholar
• . Epstein JN, Casey BJ, Tonev ST, . ADHD- and medication-related brain activation effects in concordantly affected parent-child dyads with ADHD. J Child Psychol Psychiatry. 2007;48(9):899–913
   PubMed Web of Science ®Google Scholar
• . Casey BJ, Durston S. From behavior to cognition to the brain and back: what have we learned from functional imaging studies of attention deficit hyperactivity disorder? Am J Psychiatry. 2006;163(6):957–960
   Google Scholar
• . Bush G, Spencer TJ, Holmes J, . Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task. Arch Gen Psychiatry. 2008;65(1):102–114
   PubMed Web of Science ®Google Scholar
• . McGuffin P, Riley B, Plomin R. Toward behavioral genomics. Science. 2001;291(5507):1232–1249
   Google Scholar
• . Faraone S, Biederman J. Genetics of attention-deficit hyperactivity disorder. Child Adolesc Psychiatr Clin North Am. 1994;3(2):285–302
   Google Scholar
• . Goodman R, Stevenson J. A twin study of hyperactivity—II: the aetiological role of genes, family relationships and perinatal adversity. J Child Psychol Psychiatry. 1989;30(5):691–709
   PubMed Web of Science ®Google Scholar
• . Levy F, Hay D, McStephen M, Wood C, Waldman I. Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study. J Am Acad Child Adolesc Psychiatry. 1997;36(6):737–744
   PubMed Web of Science ®Google Scholar
• . Faraone SV. Genetics of adult attention deficit hyperactivity disorder. In: Spencer T, ed. Psychiatric Clinics of North America. Vol 27. Philadelphia, PA: Saunders Press; 2004:303–321
   Google Scholar
• . Rietveld MJ, Hudziak JJ, Bartels M, van Beijsterveldt CE, Boomsma DI. Heritability of attention problems in children: longitudinal results from a study of twins, age 3 to 12. J Child Psychol Psychiatry. 2004;45(3):577–588
   PubMedGoogle Scholar
• . Pelham W, Wheeler T, Chronis A. Empirically supported psychosocial treatments for attention deficit hyperactivity disorder. J Clin Child Psychol. 1998;27(2):190–205
   PubMedGoogle Scholar
• . Chronis AM, Jones HA, Raggi VL. Evidence-based psychosocial treatments for children and adolescents with attention-deficit/hyperactivity disorder. Clin Psychol Rev. 2006;26(4):486–502
   PubMed Web of Science ®Google Scholar
• . van den Hoofdakker BJ, van der Veen-Mulders L, Sytema S, Emmelkamp PM, Minderaa RB, Nauta MH. Effectiveness of behavioral parent training for children with ADHD in routine clinical practice: a randomized controlled study. J Am Acad Child Adolesc Psychiatry. 2007;46(10):1263–1271
   PubMed Web of Science ®Google Scholar
• . Barkley R. Attention-Deficit/Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. Ed 3. New York, NY: Guilford Press; 2005
   Google Scholar
• . Abikoff H. Cognitive training in ADHD children: less to it than meets the eye. J Learn Disabl. 1991;24:205–209
   PubMed Web of Science ®Google Scholar
• . McDermott SP, Wilens TE. Cognitive therapy for adults with ADHD. In: Brown T, ed. Subtypes of Attention Deficit Disorders in Children, Adolescents, and Adults. Washington, DC: American Psychiatric Press, Inc; 2000:569–606
   Google Scholar
• . Safren SA, Otto M, Sprich S, Winett C, Wilens T, Biederman J. Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behav Res Ther. 2005;43(7):831–842
   PubMed Web of Science ®Google Scholar
• . Solanto MV, Marks DJ, Mitchell KJ, Wasserstein J, Kofman MD. Development of a new psychosocial treatment for adult ADHD. J Attention Disord. 2008;11(6):728–736
   PubMed Web of Science ®Google Scholar
• . Toplak ME, Connors L, Shuster J, Knezevic B, Parks S. Review of cognitive, cognitive-behavioral, and neural-based interventions for attention-deficit/hyperactivity disorder (ADHD). Clin Psychol Rev. 2008;28(5):801–823
   PubMed Web of Science ®Google Scholar
• . Solanto MV, Marks DJ, Wasserstein J, . Efficacy of meta-cognitive therapy for adult ADHD. Am J Psychiatry. 2010;167(8):958–968
   PubMed Web of Science ®Google Scholar
• . Hechtman L, Abikoff H, Klein RG, . Academic achievement and emotional status of children With ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. J Am Acad Child Adolesc Psychiatry. 2004;43(7):812–819
   PubMed Web of Science ®Google Scholar
• . MTA Cooperative Group. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999;56(12):1088–1096
   PubMed Web of Science ®Google Scholar
• . MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry. 1999;56(12):1073–1086
   PubMed Web of Science ®Google Scholar
• . Wilens T. Mechanism of action of agents used in ADHD. J Clin Psychiatry. 2006;67( suppl 8):32–37
   PubMed Web of Science ®Google Scholar
• . Spencer T, Biederman J, Ciccone P, . A PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short and long-acting orally administered formulations of methylphenidate in adults. Am J Psychiatry. 2006;163(3):387–395
   PubMed Web of Science ®Google Scholar
• . Parasrampuria DA, Schoedel KA, Schuller R, . Do formulation differences alter abuse liability of methylphenidate? A placebo-controlled, randomized, double-blind, crossover study in recreational drug users. J Clin Psychopharmacol. 2007;27(5):459–467
   PubMed Web of Science ®Google Scholar
• . Greenhill L, Osman B. Ritalin: Theory and Practice. New York, NY: Mary Ann Liebert; 1999
   Google Scholar
• . Greenhill L, Kollins S, Abikoff H, . Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry. 2006;45(11):1284–1293
   PubMed Web of Science ®Google Scholar
• . Wilens TE. Pharmacotherapy of ADHD in adults. CNS Spectr. 2008;13 (5 suppl 8):11–13
   Google Scholar
• . Barkley RA, McMurray MB, Edelbrock CS, Robbin K. Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation. Pediatrics. 1990;86(2):184–192
   PubMed Web of Science ®Google Scholar
• . Safer D, Allen R, Barr E. Depression of growth in hyperactive children on stimulant drugs. N Engl J Med. 1972;287(5):217–220
   PubMed Web of Science ®Google Scholar
• . MTA Cooperative Group. National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. Pediatrics. 2004;113(4):762–769
   PubMed Web of Science ®Google Scholar
• . Gadow K, Sverd J, Sprafkin J, Nolan E, Grossman S. Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder. Arch Gen Psychiatry. 1999;56(4):330–336
   PubMed Web of Science ®Google Scholar
• . Castellanos FX, Giedd JN, Elia J, . Controlled stimulant treatment of ADHD and comorbid tourette's syndrome: effects of stimulant and dose. J Am Acad Child Adolesc Psychiatry. 1997;36(5):589–596
   Google Scholar
• . Rappley MD, Moore JW, Dokken D. ADHD drugs and cardiovascular risk. N Engl J Med. 2006;354(21):2296–2298
   Google Scholar
• . Gutgesell H, Atkins D, Barst R, . Cardiovascular monitoring of children and adolescents receiving psychotropic drugs: a statement for healthcare professionals from the Committee on Congenital Cardiac Defects, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 1999;99(7):979–982
   PubMedGoogle Scholar
• . Perrin JM, Friedman RA, Knilans TK. Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder. Pediatrics. 2008;122(2):451–153
   Google Scholar
• . Wilens TE, Gignac M, Swezey A, Monuteaux MC, Biederman J. Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications. J Am Acad Child Adolesc Psychiatry. 2006;45(4):408–414
   PubMed Web of Science ®Google Scholar
• . Wilens TE, Adler LA, Adamson J, . Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry. 2008;47(1):21–31
   PubMed Web of Science ®Google Scholar
• . McCabe SE, Knight JR, Teter CJ, Wechsler H. Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey. Addiction. 2005;99(1):96–106
   Google Scholar
• . Michelson D, Faries D, Wernicke J, . Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study. Pediatrics. 2001;108(5):E83
   PubMed Web of Science ®Google Scholar
• . Michelson D, Allen AJ, Busner J, . Once-daily atomoxetine treatment for children and adolescents with ADHD: a randomized, placebo-controlled study. Am J Psychiatry. 2002;159(11):1896–1901
   PubMed Web of Science ®Google Scholar
• . Michelson D, Buitelaar JK, Danckaerts M, . Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry. 2004;43(7):896–904
   PubMedGoogle Scholar
• . Geller D, Donnelly C, Lopez F, . Atomoxetine treatment for pediatric patients with attention-deficit/hyperactivity disorder with comorbid anxiety disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(9):1119–1127
   Google Scholar
• . Wilens TE, Adler LA, Weiss MD, . Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. Drug Alcohol Depend. 2008;96(1–2):145–154
   PubMed Web of Science ®Google Scholar
• . Eli Lilly and Co. Strattera (atomoxetine HCl). Important Safety Information. http://www.strattera.com/pages/index.aspx. Accessed August 12, 2010
   Google Scholar
• . Sallee F, McGough J, Wigal T, Donahue J, Lyne A, Biederman J. Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trial. J Am Acad Child Adolesc Psychiatry. 2009;48(2):155–165
   PubMed Web of Science ®Google Scholar
• . Connor DF, Fletcher KE, Swanson JM. A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1999;38(12):1551–1559
   PubMed Web of Science ®Google Scholar
• . Kurlan R. Methylphenidate to treat ADHD is not contraindicated in children with tics. Movement Disord. 2002;17(1):5–6
   PubMedGoogle Scholar
• . Hazell PL, Stuart JE. A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children. J Am Acad Child Adoelsc Psychiatry. 2003;42(8):886–894
   PubMed Web of Science ®Google Scholar
• . Palumbo DR, Sallee FR, Pelham WE Jr, Bukstein OG, Daviss WB, McDermott MP. Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes. J Am Acad Child Adolesc Psychiatry. 2008;47(2):180–188
   PubMed Web of Science ®Google Scholar
• . Spencer TJ, Greenbaum M, Ginsberg LD, Murphy WR. Safety and effectiveness of coadministration of guanfacine extended release and psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2009;19(5):501–510
   PubMed Web of Science ®Google Scholar
• . Wilens T, Youcha SH, Lyne A, Grannis K, Children A, Findling RL. A multisite placebo-controlled trial of morning or evening dosed extended-release guanfacine in combination with psychostimulants in children and adolescents. Paper presented at: Scientific Meetings of the Society of Biological Psychiatry; May 20–22, 2010; New Orleans, LA
   Google Scholar
• . Conners CK, Casat CD, Gualtieri CT, . Bupropion hydrochloride in attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry. 1996;35(10):1314–1321
   PubMed Web of Science ®Google Scholar
• . Wilens TE, Spencer TJ, Biederman J, . A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. Am J Psychiatry. 2001;158(2):282–288
   PubMed Web of Science ®Google Scholar
• . Wilens T, Haight BR, Horrigan JP, . Bupropion XL in adults with ADHD: a randomized, placebo-controlled study. Biol Psychiatry. 2005;57(7):793–801
   PubMed Web of Science ®Google Scholar
• . Daviss WB, Bentivoglio P, Racusin R, Brown KM, Bostic JQ, Wiley L. Bupropion sustained release in adolescents with comorbid attention-deficit/hyperactivity disorder and depression. J Am Acad Child Adolesc Psychiatry. 2001;40(3):307–314
   Google Scholar
• . Wilens T, Prince J, Spencer T, . An open trial of bupropion for the treatment of adults with attention deficit hyperactivity disorder and bipolar disorder. Biol Psychiatry. 2003;54(1):9–16
   PubMed Web of Science ®Google Scholar
• . Spencer T, Biederman J, Wilens T. Pharmacotherapy of attention-deficit/hyperactivity disorder: a life span perspective. In: Dickstein L, Riba M, Oldham J, eds. Review of Psychiatry. Vol 16. Washington, DC: American Psychiatric Press; 1998:IV87–IV127
   Google Scholar
• . Biederman J, Pliszka SR. Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents. J Pediatr. 2008;152(3):394–399
   PubMed Web of Science ®Google Scholar